These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 3587469)
1. Serum guanidino compound levels and the influence of a single hemodialysis in uremic patients undergoing maintenance hemodialysis. De Deyn P; Marescau B; Lornoy W; Becaus I; Van Leuven I; Van Gorp L; Lowenthal A Nephron; 1987; 45(4):291-5. PubMed ID: 3587469 [TBL] [Abstract][Full Text] [Related]
2. Serum guanidino compound levels in uremic pediatric patients treated with hemodialysis or continuous cycle peritoneal dialysis. Correlations between nerve conduction velocities and altered guanidino compound concentrations. De Deyn PP; Robitaille P; Vanasse M; Qureshi IA; Marescau B Nephron; 1995; 69(4):411-7. PubMed ID: 7777105 [TBL] [Abstract][Full Text] [Related]
3. Serum guanidino compound levels and clearances in uremic patients treated with continuous ambulatory peritoneal dialysis. De Deyn PP; Marescau B; Swartz RD; Hogaerth R; Possemiers I; Lowenthal A Nephron; 1990; 54(4):307-12. PubMed ID: 2325795 [TBL] [Abstract][Full Text] [Related]
5. Guanidino compound levels in brain regions of non-dialyzed uremic patients. De Deyn PP; Marescau B; D'Hooge R; Possemiers I; Nagler J; Mahler C Neurochem Int; 1995 Sep; 27(3):227-37. PubMed ID: 8520461 [TBL] [Abstract][Full Text] [Related]
6. Plasma, urinary, and erythrocyte concentrations of guanidino compounds in patients with chronic renal failure. Tanaka A; Takahashi Y; Mizokuchi M; Shimada N; Koide H Ren Fail; 1999 Sep; 21(5):499-514. PubMed ID: 10516995 [TBL] [Abstract][Full Text] [Related]
7. Convulsive action and toxicity of uremic guanidino compounds: behavioral assessment and relation to brain concentration in adult mice. D'Hooge R; Pei YQ; Marescau B; De Deyn PP J Neurol Sci; 1992 Oct; 112(1-2):96-105. PubMed ID: 1469446 [TBL] [Abstract][Full Text] [Related]
8. Automatic system for the assay of guanidino compounds to assess uremic status and effect of hemodialysis. Nohara Y; Hanai T; Suzuki J; Matsumoto G; Iinuma F; Kubo H; Kinoshita T Chem Pharm Bull (Tokyo); 1998 Nov; 46(11):1844-5. PubMed ID: 9845964 [TBL] [Abstract][Full Text] [Related]
9. Guanidino compounds in serum and cerebrospinal fluid of non-dialyzed patients with renal insufficiency. De Deyn PP; Marescau B; Cuykens JJ; Van Gorp L; Lowenthal A; De Potter WP Clin Chim Acta; 1987 Jul; 167(1):81-8. PubMed ID: 3665089 [TBL] [Abstract][Full Text] [Related]
10. Automatic system for the assay of guanidino compounds to assess uremic status. Nohara Y; Hanai T; Suzuki J; Matsumoto G; Iinuma F; Kubo H; Kinoshita T; Watanabe M Biol Pharm Bull; 2000 Sep; 23(9):1015-20. PubMed ID: 10993196 [TBL] [Abstract][Full Text] [Related]
11. Liquid-chromatographic determination of guanidino compounds in plasma and erythrocyte of normal persons and uremic patients. Kikuchi T; Orita Y; Ando A; Mikami H; Fujii M; Okada A; Abe H Clin Chem; 1981 Nov; 27(11):1899-902. PubMed ID: 7296840 [TBL] [Abstract][Full Text] [Related]
12. Guanidino compounds that are increased in cerebrospinal fluid and brain of uremic patients inhibit GABA and glycine responses on mouse neurons in cell culture. De Deyn PP; Macdonald RL Ann Neurol; 1990 Nov; 28(5):627-33. PubMed ID: 2135950 [TBL] [Abstract][Full Text] [Related]
13. Erythrocyte transketolase activity and guanidino compounds in hemodialysis patients. Pietrzak I; Baczyk K Kidney Int Suppl; 2001 Feb; 78():S97-101. PubMed ID: 11168992 [TBL] [Abstract][Full Text] [Related]
14. Fast atom bombardment mass spectrometric determination of the molecular weight range of uremic compounds that displace phenytoin from protein binding: absence of midmolecular uremic toxins. Dasgupta A; Malik S Am J Nephrol; 1994; 14(3):162-8. PubMed ID: 7977474 [TBL] [Abstract][Full Text] [Related]
15. Gas chromatographic determination of guanidino compounds in uremic patients using glyoxal as derivatizing reagent. Majidano SA; Khuhawar MY J Chromatogr Sci; 2012 May; 50(5):380-6. PubMed ID: 22392369 [TBL] [Abstract][Full Text] [Related]
16. High-performance liquid chromatographic analysis of guanidino compounds using ninhydrin reagent. II. Guanidino compounds in blood of patients on haemodialysis therapy. Hiraga Y; Kinoshita T J Chromatogr; 1985 Aug; 342(2):269-75. PubMed ID: 4055949 [TBL] [Abstract][Full Text] [Related]
17. Depressed natural killer cell activity in uremia. Evidence for immunosuppressive factor in uremic sera. Asaka M; Iida H; Izumino K; Sasayama S Nephron; 1988; 49(4):291-5. PubMed ID: 3261845 [TBL] [Abstract][Full Text] [Related]
18. Guanidino compounds in serum and urine of nondialyzed patients with chronic renal insufficiency. Marescau B; Nagels G; Possemiers I; De Broe ME; Becaus I; Billiouw JM; Lornoy W; De Deyn PP Metabolism; 1997 Sep; 46(9):1024-31. PubMed ID: 9284891 [TBL] [Abstract][Full Text] [Related]
19. [Guanidino-succinic acid in uremic patients treated with periodic hemodialysis]. Man NK; Rondon-Nucete M; Kamoun PP; Pleau JM; Zingraff J; Jungers P J Urol Nephrol (Paris); 1972 Sep; 78(9):750-5. PubMed ID: 4660657 [No Abstract] [Full Text] [Related]
20. Influence of 72% injury in one kidney on several organs involved in guanidino compound metabolism: a time course study. Levillain O; Marescau B; Possemiers I; Al Banchaabouchi M; De Deyn PP Pflugers Arch; 2001 Jul; 442(4):558-69. PubMed ID: 11510889 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]